LUCY RSI Chart
Last 7 days
-5%
Last 30 days
-26.9%
Last 90 days
-54.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 1.4M | 0 | 0 | 0 |
2023 | 568.7K | 533.9K | 603.8K | 1.2M |
2022 | 682.9K | 675.2K | 667.5K | 659.8K |
2021 | 0 | 0 | 0 | 690.7K |
Which funds bought or sold LUCY recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | MORGAN STANLEY | unchanged | - | -537 | 984 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | unchanged | - | -37.00 | 68.00 | -% |
May 15, 2024 | SABBY MANAGEMENT, LLC | new | - | 5,242,000 | 5,242,000 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 0.89 | -1,224 | 2,299 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | new | - | 7,976 | 7,976 | -% |
May 15, 2024 | Hudson Bay Capital Management LP | unchanged | - | 3,879 | 9,982 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | added | 1.91 | 1,297 | 3,249 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | new | - | 10,888 | 10,888 | -% |
May 13, 2024 | UBS Group AG | sold off | -100 | -4,458 | - | -% |
May 13, 2024 | CLEAR STREET LLC | reduced | -0.06 | 6,000 | 15,000 | -% |
Unveiling Innovative Eyewear, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Innovative Eyewear, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Innovative Eyewear, Inc. News
Income Statement (Quarterly) | |||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 |
Revenue | -37.7% | 383 | 616 | 222 | 170 | 145 | 67.00 | 152 | 205 | 236 | 204 | 171 | 127 |
Cost Of Revenue | -52.7% | 377 | 796 | 142 | 200 | 135 | 264 | 129 | 161 | 162 | - | 130 | 94.00 |
Gross Profit | 103.9% | 7.00 | -180 | 80.00 | -29.82 | 10.00 | -196 | 23.00 | 43.00 | 74.00 | - | 41.00 | 33.00 |
Operating Expenses | -12.7% | 2,022 | 2,315 | 1,677 | 1,304 | 1,439 | 1,680 | 1,389 | 1,190 | 1,263 | - | 1,132 | 550 |
S&GA Expenses | -42.5% | 661 | 1,150 | 534 | 104 | 259 | 513 | 569 | 392 | 585 | - | 513 | 271 |
R&D Expenses | 79.0% | 216 | 121 | 193 | 197 | 151 | 132 | 305 | 53.00 | 36.00 | - | 9.00 | 19.00 |
Interest Expenses | - | - | - | - | 1.00 | 2.00 | 4.00 | 38.00 | 45.00 | 18.00 | - | 10.00 | 15.00 |
Net Income | 17.6% | -1,971 | -2,393 | -1,551 | -1,287 | -1,430 | -1,877 | -1,404 | -1,193 | -1,206 | -1,385 | -1,100 | -536 |
Net Income Margin | 10.4% | -5.18* | -5.78* | -10.18* | -11.24* | -10.39* | -8.61* | -7.78* | -7.24* | -6.19* | -4.70* | - | - |
Free Cashflow | -35.1% | -1,499 | -1,109 | -1,429 | -1,850 | -1,455 | -1,148 | -1,020 | -513 | -662 | - | - | - |
Balance Sheet | ||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2021Q4 |
Assets | -22.6% | 4,813 | 6,219 | 8,116 | 9,340 | 5,113 | 4,690 | 6,418 | 1,101 | 824 |
Current Assets | -26.8% | 4,111 | 5,617 | 7,501 | 8,770 | 4,542 | 4,241 | 6,102 | 835 | 644 |
Cash Equivalents | -38.2% | 2,649 | 4,287 | 3,904 | 5,356 | 3,450 | 3,591 | 4,976 | 35.00 | 80.00 |
Inventory | 61.1% | 859 | 533 | 776 | 660 | 743 | 95.00 | 423 | 325 | 276 |
Net PPE | 8.0% | 143 | 133 | 178 | 125 | 138 | 120 | 98.00 | 53.00 | 20.00 |
Liabilities | 38.1% | 911 | 660 | 474 | 389 | 563 | 665 | 851 | 2,453 | 617 |
Current Liabilities | 41.5% | 883 | 624 | 431 | 331 | 505 | 600 | 851 | 2,453 | 617 |
LT Debt, Current | - | - | - | - | - | - | 61.00 | 166 | 1,938 | 289 |
Shareholder's Equity | -29.8% | 3,902 | 5,559 | 7,642 | 8,951 | 4,550 | 4,024 | 5,567 | - | 208 |
Retained Earnings | -11.6% | -18,940 | -16,969 | -14,575 | -13,024 | -11,736 | -10,305 | -8,428 | -7,024 | -4,624 |
Additional Paid-In Capital | 1.4% | 22,842 | 22,528 | 22,218 | 21,976 | 16,287 | 14,330 | 14,000 | 5,677 | 4,843 |
Shares Outstanding | 0.1% | 12,934 | 12,917 | 12,917 | 12,917 | 7,716 | 7,307 | 6,673 | 6,060 | 6,060 |
Float | - | - | - | - | 6,917 | - | - | - | - | - |
Cashflow (Quarterly) | |||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 |
Cashflow From Operations | -29.2% | -1,467 | -1,135 | -1,359 | -1,843 | -1,427 | -1,117 | -970 | -505 | -630 | - | - | - |
Share Based Compensation | -25.2% | 232 | 310 | 242 | -40.18 | 424 | 335 | 305 | 417 | 417 | - | - | - |
Cashflow From Investing | -104.8% | -95.54 | 2,010 | -93.42 | -1,978 | -136 | -64.52 | -57.67 | -15.09 | -82.66 | - | - | - |
Cashflow From Financing | 84.5% | -75.99 | -490 | - | 5,729 | 1,423 | -203 | 5,970 | 513 | 676 | - | - | - |
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenues, net | $ 383,471 | $ 144,921 |
Less: Cost of Goods Sold | (376,520) | (134,630) |
Gross Profit | 6,951 | 10,291 |
Operating Expenses: | ||
General and administrative | (1,108,946) | (993,772) |
Sales and marketing | (661,295) | (259,297) |
Research and development | (216,301) | (151,169) |
Related party management fee | (35,000) | (35,000) |
Total Operating Expenses | (2,021,542) | (1,439,238) |
Other Income (Expense) | 43,280 | 76 |
Interest Expense | (1,939) | |
Total Other Income (Expense), net | 43,280 | (1,863) |
Net Loss | $ (1,971,311) | $ (1,430,810) |
Weighted average number of shares outstanding, basic | 12,952,106 | 7,569,115 |
Weighted average number of shares outstanding, diluted | 12,952,106 | 7,569,115 |
Loss per share, basic | $ (0.15) | $ (0.19) |
Loss per share, diluted | $ (0.15) | $ (0.19) |
CONDENSED BALANCE SHEETS (Unaudited) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current Assets | ||
Cash and cash equivalents | $ 2,648,566 | $ 4,287,447 |
Accounts receivable, net of allowances of $21,437 and $25,772, respectively | 52,779 | 93,211 |
Prepaid expenses | 425,867 | 313,648 |
Inventory prepayment | 59,407 | 323,520 |
Inventory | 858,905 | 533,239 |
Due from Tekcapital and Affiliates | 5,830 | 6,256 |
Other current assets | 59,447 | 59,447 |
Total Current Assets | 4,110,801 | 5,616,768 |
Non-Current Assets | ||
Patent costs, net | 330,192 | 286,429 |
Capitalized software costs | 110,073 | 110,073 |
Property and equipment, net | 143,487 | 132,848 |
Other non-current assets | 118,458 | 72,644 |
TOTAL ASSETS | 4,813,011 | 6,218,762 |
Current Liabilities | ||
Accounts payable and accrued expenses | 840,992 | 581,986 |
Deferred revenue | 42,500 | 42,500 |
Total Current Liabilities | 883,492 | 624,486 |
Non-Current Liabilities | ||
Deferred revenue | 27,950 | 35,450 |
TOTAL LIABILITIES | 911,442 | 659,936 |
Commitments and contingencies (Note 7) | ||
Stockholders’ Equity | ||
Common stock (par value $0.00001, 50,000,000 shares authorized, and 13,233,544 and 12,917,239 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively) | 132 | 129 |
Additional paid-in capital | 22,842,163 | 22,528,112 |
Accumulated deficit | (18,940,726) | (16,969,415) |
TOTAL STOCKHOLDERS’ EQUITY | 3,901,569 | 5,558,826 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 4,813,011 | $ 6,218,762 |